Chembio develops, manufactures and markets point-of-care diagnosing products for the detection of infectious diseases.Read more
Chembio's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 452.1M. Over the last four quarters, Chembio's revenue has decreased by 37.1%. Specifically, in Q2 2021's revenue was $6.5M; in Q1 2021, it was $8.7M; in Q4 2020, it was $10.2M; in Q3 2020, Chembio's revenue was $10.3M.